Hospital system unveils oncology research center; Genetic technique diagnoses super-rare diseases;

Cancer Research

> The Greenville, SC, Hospital System University Medical Center (GHS) unveiled details of its new Institute for Translational Oncology Research. The new institute, known as ITOR, builds on the success of GHS' Clinical Research Unit and its rapidly developing biorepository tissue-banking service. Release

Genetics

> A test could help identify women at risk for early menopause. Article Release

> New genetic techniques diagnose illnesses so mysterious they have no name. Article

> The La Jolla Institute for Allergy & Immunology will develop San Diego's first Center for RNAi screening. It’s made possible by a $12.6 million award from the NIH. Release

> A new study by pediatric researchers has added to the evidence that genes have a strong influence on childhood obesity. Release

Stem Cell Research

> International Stem Cell Corp. will partner with marketer John Mauldin to launch new stem-cell-based “skin care products.” Release and shares of the company jump 21 percent Report

> Scientists identify a gene that prevents stem cells from turning cancerous. Release

> Canada does its first animal in-clinic stem cell procedure on a Newf named Lexi. Report

And Finally... Sorry, Captain Kirk. Sex is space might be a very bad idea. Report

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.